Jubilant Biosys Limited Revenue and Competitors

Morrisville, PA USA

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • Jubilant Biosys Limited's estimated annual revenue is currently $256.2M per year.(i)
  • Jubilant Biosys Limited's estimated revenue per employee is $142,800

Employee Data

  • Jubilant Biosys Limited has 1794 Employees.(i)
  • Jubilant Biosys Limited grew their employee count by -1% last year.

Jubilant Biosys Limited's People

NameTitleEmail/Phone
1
VPReveal Email/Phone
2
Head Logistics DepartmentReveal Email/Phone
3
Director Business Development, Head EuropeReveal Email/Phone
4
DirectorReveal Email/Phone
5
Assistant DirectorReveal Email/Phone
6
Senior Research AssociateReveal Email/Phone
7
Senior Research ScientistReveal Email/Phone
8
Senior Manager-FinanceReveal Email/Phone
9
Senior ExecutiveReveal Email/Phone
10
Team leaderReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M5714%N/AN/A
#2
$205.9M14424%N/AN/A
#3
$52.4M4116%N/AN/A
#4
$21.7M1935%N/AN/A
#5
$5.5M603%N/AN/A
#6
$5.1M5610%N/AN/A
#7
$1.1M18-44%N/AN/A
#8
$0.3M50%N/AN/A
#9
$0.1M20%N/AN/A
#10
$2.7M336%N/AN/A
Add Company

What Is Jubilant Biosys Limited?

Jubilant Biosys Ltd (JBL) offers services in Structural Biology, Computational Chemistry, Medicinal Chemistry, in-vitro and in-vivo Biology, DMPK and Toxicology areas to various pharmaceutical and biotechnology. Jubilant Biosys Limited (JBL) is a subsidiary of Jubilant Life Sciences (a $1.3 Bn Sales Corporation) providing innovative drug discovery services to the global life sciences, agrochemicals and specialty chemicals industry through its research centers in India. Jubilant's services in discovery research include; Jubilant's services in discovery research includes; • Target Identification/Target Validation to Lead Optimization/ Preclinical candidate, for multiple therapeutic areas viz; Oncology, Metabolic Disorders, CNS, Pain, Inflammation, Fibrosis and Respiratory diseases. • Functional services comprising of computational chemistry/ molecular modeling, medicinal chemistry, synthetic chemistry, scale-up (Non-GMP & GMP), structural biology, ADME-PK,in-vitro and in-vivo biology and IND enabling GLP toxicology.

keywords:N/A

N/A

Total Funding

1794

Number of Employees

$256.2M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Jubilant Biosys Limited News

2022-04-17 - New Research report on Drug Discovery Informatics Market ...

... to 2029 | Key Company's – Jubilant Biosys, IBM, Dassault Systèmes ... GVK Biosciences Private Limited, Collaborative Drug Discovery,...

2022-04-13 - Drug Discovery Informatics Market Size, Trends And Forecast ...

Infosys Ltd., Charles River Laboratories, Collaborative Drug Discovery, Inc., Eurofins DiscoverX Products, Jubilant Biosys, Selvita,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$622.9M30994%N/A
#2
$535.3M388915%N/A
#3
$916.2M45589%N/A
#4
$12980M53765%N/A
#5
$1775.2M8745N/AN/A